Stockreport

Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

Entrada Therapeutics, Inc.  (TRDA) 
PDF – Company on track to report ELEVATE-44-201 data from Cohort 1 in Q2 2026 and Cohort 2 by year-end 2026 – – Company on track to report ELEVATE-45-201 data from Cohort 1 [Read more]